Table 1.
RICOVER-60 study—age groups patients 61–80 years, 6-CHOP-14 + 8xR (n = 306) demographics
| 61–65 years | 66–70 years | 71–75 years | 76–80 years | |
|---|---|---|---|---|
| n = 90 | n = 103 | n = 73 | n = 40 | |
| Male | 54 (60%) | 59 (57%) | 34 (47%) | 21 (52%) |
| Female | 36 (40%) | 44 (43%) | 39 (53%) | 19 (48%) |
| Age, median (range) | 62 (61, 65) | 68 (66, 70) | 73 (71, 75) | 78 (76, 80) |
| LDH > UNV | 39 (43%) | 45 (44%) | 37 (51%) | 31 (78%) |
| ECOG > 1 | 13 (14%) | 10 (10%) | 9 (12%) | 11 (28%) |
| Stage III/IV | 52 (58%) | 50 (48%) | 26 (36%) | 24 (60%) |
| Extranod. involvement > 1 | 17 (19%) | 21 (20%) | 6 (8%) | 8 (20%) |
| IPI 1 | 29 (32%) | 34 (33%) | 26 (36%) | 5 (12%) |
| 2 | 24 (27%) | 32 (31%) | 23 (32%) | 10 (25%) |
| 3 | 22 (24%) | 24 (23%) | 19 (26%) | 13 (32%) |
| 4, 5 | 15 (17%) | 13 (13%) | 5 (7%) | 12 (30%) |
| Extranod. involvem. | 40 (44%) | 59 (57%) | 43 (59%) | 19 (48%) |
| Bulky disease | 42 (47%) | 36 (35%) | 22 (30%) | 17 (42%) |
| B symptoms | 36 (40%) | 26 (25%) | 23 (32%) | 13 (32%) |
| BM involvement | 4 (4%) | 5 (5%) | 2 (3%) | 3 (8%) |